Since 1994, NCARD has created a biobank of patient samples to facilitate research aimed at delivering improved clinical outcomes to the people of Western Australia and around the world.
Based at Sir Charles Gairdner Hospital (SCGH), the NCARD Biobank consists of a group of clinicians and scientists dedicated to medical research focused on improving diagnosis and treatment of asbestos-related diseases such as mesothelioma, as well as other health conditions. The Biobank has been partially funded by a National Health and Medical Research Council Centre of Research Excellence grant.
The biobank has supported over thirty different projects with approximately 10,000 bio specimens prepared from de-identified samples donated for medical research. In addition, around 80 cancer cell lines have been established.